COVID-19 leads to high in-hospital mortality in patients with pulmonary hypertension
September 29, 2022 2 min reading Source/Disclosure Disclosure: Montani reports that the institution receives grants or contracts from Acceleron, Janssen, and Merck; consulting fees from Acceleron; and honoraria from Bayer, Janssen, and Merck. Please see the study for all the relevant financial data of the other authors. ADD SUBJECT TO EMAIL NOTIFICATIONS Receive an email …
COVID-19 leads to high in-hospital mortality in patients with pulmonary hypertension Read More »